Table 2.
Treatment group | N | Retention rate, n (%) | Contrasts | Estimated difference (97.5% CI) | Outcome |
Lumiracoxib 100 mg | 755 | 354 (46.9) | Lumiracoxib 100 mg o.d. | 0.02 (-0.04, 0.07) | Non-inferior |
o.d. | - celecoxib 200 mg o.d. | ||||
Lumiracoxib 100 mg | 1519 | 722 (47.5) | Lumiracoxib 100 mg b.i.d. | 0.02 (-0.03, 0.07) | Non-inferior |
b.i.d. | - celecoxib 200 mg o.d. | ||||
Celecoxib 200 mg | 758 | 343 (45.3) | |||
o.d. |
CI = confidence interval; o.d. = once daily; b.i.d. = twice daily; ITT = intention-to-treat.